Document is current
Any future updates will be listed below
-
Authors
Yang, Baiyu
Wasserman, Erin B.
Somoskovi, Akos
Jarem, Daniel
Volkir, Patrick
Mack, Christina
Baumfeld Andre, Elodie
-
Funding
Funding for this research was provided by:
Roche Molecular Systems, Inc.
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 18 February 2026
First Online: 15 March 2026
Declarations
:
: Baiyu Yang and Elodie Baumfeld Andre were employees of Roche Molecular Systems at the time of this study and hold shares in F Hoffmann-La Roche. Erin B. Wasserman is a full-time employee of IQVIA. Akos Somoskovi, Daniel Jarem, and Patrick Volkir are full-time employees of Roche Molecular Systems and hold shares in F Hoffmann-La Roche. Christina Mack is a full-time employee of IQVIA and holds stock in IQVIA, AstraZeneca, Johnson & Johnson and MindMed.
: This analysis was conducted in accordance with applicable regulations. As the data used were from an occupational monitoring program (as opposed to a research study), no separate IRB submission was required and individuals were not required to provide written, informed consent. Both the NFL and the NFLPA approved the submission of the master data file to the FDA.
: COBAS is a trademark of Roche. All other product names and trademarks are the property of their respective owners.
